Showing results (251-260 of 1,659) with videos related to
Sort By:
Pageof 166
Vascular Health and Risk Management|July 22, 2014
Carotid revascularization: risks and benefitsMarlene O'Brien, Ankur ChandraVascular Health and Risk Management|December 3, 2013
Visceral obesity is not an independent risk factor of mortality in subjects over 65 yearsFrédérique Thomas, Bruno Pannier, Athanase Benetos, et al.Vascular Health and Risk Management|August 29, 2013
Current status of NADPH oxidase research in cardiovascular pharmacologyBruno K Rodiño-Janeiro, Beatriz Paradela-Dobarro, María Isabel Castiñeiras-Landeira, et al.Vascular Health and Risk Management|September 17, 2013
Safety, tolerability, and efficacy of a fixed-dose combination of olmesartan 40 mg and hydrochlorothiazide 12.5/25 mg in daily practicePeter Bramlage, Claudia Zemmrich, Reinhard Ketelhut, et al.Vascular Health and Risk Management|September 17, 2013
Perceptions of barriers to cardiac rehabilitation use in BrazilGabriela Lima de Melo Ghisi, Rafaella Zulianello dos Santos, Eduardo Eugênio Aranha, et al.Vascular Health and Risk Management|November 26, 2015
Type of dyslipidemia and achievement of the LDL-cholesterol goal in chronic kidney disease patients at the University HospitalTamon Sangsawang, Apiradee SriwijitkamolVascular Health and Risk Management|November 26, 2015
Effectiveness and tolerability of treatment intensification to basal-bolus therapy in patients with type 2 diabetes on previous basal insulin-supported oral therapy with insulin glargine or supplementary insulin therapy with insulin glulisine: the PARTNER observational studyMartin Pfohl, Thorsten Siegmund, Stefan Pscherer, et al.Vascular Health and Risk Management|October 2, 2015
The MGuard coronary stent: safety, efficacy, and clinical utilityMontserrat Gracida, Rafael Romaguera, Francisco Jacobi, et al.Vascular Health and Risk Management|August 29, 2015
Subcutaneous adipose tissue plays a beneficial effect on subclinical atherosclerosis in young survivors of acute lymphocytic leukemiaAdriana Aparecida Siviero-Miachon, Angela Maria Spinola-Castro, Maria Lucia de Martino Lee, et al.Vascular Health and Risk Management|January 8, 2015
Overview of saxagliptin efficacy and safety in patients with type 2 diabetes and cardiovascular disease or risk factors for cardiovascular diseasePeter P TothPageof 166